Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Aniline Compounds"" wg kryterium: Temat


Tytuł:
Synergy and antagonism between azacitidine and FLT3 inhibitors.
Autorzy:
Yang J; Department of Chemistry and Biomedical Science, Linnaeus University, Kalmar, SE-39231, Sweden.
Friedman R; Department of Chemistry and Biomedical Science, Linnaeus University, Kalmar, SE-39231, Sweden. Electronic address: .
Pokaż więcej
Źródło:
Computers in biology and medicine [Comput Biol Med] 2024 Feb; Vol. 169, pp. 107889. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Amides*
Aniline Compounds*/pharmacology
Aniline Compounds*/therapeutic use
Azacitidine*/pharmacology
Azacitidine*/therapeutic use
Benzothiazoles*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Phenylurea Compounds*
Protein Kinase Inhibitors*/pharmacology
Protein Kinase Inhibitors*/therapeutic use
Pyrazines*
Pyrimidines*
Humans ; fms-Like Tyrosine Kinase 3/genetics ; fms-Like Tyrosine Kinase 3/therapeutic use ; Mutation
Czasopismo naukowe
Tytuł:
An all-fiber system biosensor for trace β-lactam antibiotics detection enhanced by functionalized microfiber and fiber bragg grating.
Autorzy:
Sun D; School of Physics and Electronic Engineering, Shanxi University, Taiyuan, China. Electronic address: .
Hou Z; School of Physics and Electronic Engineering, Shanxi University, Taiyuan, China.
Yan H; School of Physics and Electronic Engineering, Shanxi University, Taiyuan, China.
Yang Y; School of Life Science, Shanxi University, Taiyuan 030006, China.
Wang G; School of Information and Communication Engineering, Hainan University, Haikou 570228, China.
Wu J; School of Physics and Electronic Engineering, Shanxi University, Taiyuan, China; Collaborative Innovation Center of Extreme Optics, Shanxi University, Taiyuan, China.
Ma J; School of Physics and Electronic Engineering, Shanxi University, Taiyuan, China; Collaborative Innovation Center of Extreme Optics, Shanxi University, Taiyuan, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of colloid and interface science [J Colloid Interface Sci] 2024 Mar 15; Vol. 658, pp. 903-912. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:
Journal Article
MeSH Terms:
beta Lactam Antibiotics*
Biosensing Techniques*
Aniline Compounds*
Equipment Design ; Water
Czasopismo naukowe
Tytuł:
Decreased mebrofenin uptake in patients with non-colorectal liver tumors requiring liver volume augmentation-a single-center analysis.
Autorzy:
Fard-Aghaie MH; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. .
Stern L; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Ghadban T; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Apostolova I; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Lehnert W; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Klutmann S; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Hackert T; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Izbicki JR; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Li J; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
von Kroge PH; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Heumann A; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Pokaż więcej
Źródło:
Langenbeck's archives of surgery [Langenbecks Arch Surg] 2024 Mar 11; Vol. 409 (1), pp. 92. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Liver Failure*/etiology
Colorectal Neoplasms*/diagnostic imaging
Colorectal Neoplasms*/surgery
Colorectal Neoplasms*/complications
Aniline Compounds*
Glycine*
Humans ; Radiopharmaceuticals ; Liver/diagnostic imaging ; Liver/surgery ; Hepatectomy/adverse effects ; Retrospective Studies ; Postoperative Complications
Czasopismo naukowe
Tytuł:
High-Strength, High-Swelling-Resistant, High-Sensitivity Hydrogel Sensor Prepared with Wood That Retains Lignin.
Autorzy:
Meng X; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Zhou J; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Jin X; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Xia C; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.; China Jiangsu Key Open Laboratory of Wood Processing and Wood-Based Panel Technology, Nanjing, Jiangsu 210037, China.
Ma S; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Hong S; Hollingsworth & Vose (Suzhou) Co., Ltd., Suzhou Industrial Park, Suzhou 215126, China.
Aladejana JT; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Dong A; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Luo Y; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Li J; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.
Zhan X; Dehua Tubaobao New Decoration Material Co., Ltd., Huzhou 313200, China.
Yang R; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, Jiangsu 210037, China.; China Jiangsu Key Open Laboratory of Wood Processing and Wood-Based Panel Technology, Nanjing, Jiangsu 210037, China.; Dehua Tubaobao New Decoration Material Co., Ltd., Huzhou 313200, China.
Pokaż więcej
Źródło:
Biomacromolecules [Biomacromolecules] 2024 Mar 11; Vol. 25 (3), pp. 1696-1708. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lignin*/chemistry
Hydrogels*/chemistry
Aniline Compounds*
Humans ; Wood ; Ions/chemistry ; Electric Conductivity
Czasopismo naukowe
Tytuł:
Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs.
Autorzy:
Feng R; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Zhen YQ; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, P.R. China.
Wu D; Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu 610041, P.R. China.
Sun L; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Xu JB; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Li X; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Zhang L; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Gao F; Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.
Pokaż więcej
Źródło:
Science advances [Sci Adv] 2024 Mar 08; Vol. 10 (10), pp. eadl0026. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Palladium*/chemistry
Lung Neoplasms*
Acrylamides*
Aniline Compounds*
Pyrimidines*
Humans ; Animals ; Mice ; ErbB Receptors ; Mutation ; Protein Kinase Inhibitors ; Indoles/chemistry ; Catalysis
Czasopismo naukowe
Tytuł:
Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Autorzy:
Asdemir A; Faculty of Medicine, Department of Urology, Sivas Cumhuriyet University, Sivas, Turkey. .
Özgür A; Artova Vocational School, Department of Veterinary Medicine, Laboratory and Veterinary Health Program, Tokat Gaziosmanpasa University, Tokat, Turkey.
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2024 Mar 04; Vol. 41 (4), pp. 83. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/drug therapy
Antineoplastic Agents*/pharmacology
Aniline Compounds*
Sulfonamides*
Male ; Humans ; Prostate ; Apoptosis ; Signal Transduction
Czasopismo naukowe
Tytuł:
Detection of EGFR T790M mutation using liquid biopsy for non-small cell lung cancer: Utility of droplet digital polymerase chain reaction vs. cobas real-time polymerase chain reaction.
Autorzy:
Zungsontiporn N; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Ouwongprayoon P; Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Boonsirikamchai P; Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Leelayuwatanakul N; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Vinayanuwattikun C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Moonai K; Chula GenePRO Center, Research Affairs, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Khongkhaduead E; Chula GenePRO Center, Research Affairs, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Thorner PS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; Department of Pathology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Shuangshoti S; Chula GenePRO Center, Research Affairs, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand; Department of Pathology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Teerapakpinyo C; Chula GenePRO Center, Research Affairs, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand. Electronic address: .
Pokaż więcej
Źródło:
Pathology, research and practice [Pathol Res Pract] 2024 Mar; Vol. 255, pp. 155213. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; ErbB Receptors ; Real-Time Polymerase Chain Reaction ; Protein Kinase Inhibitors/therapeutic use ; Mutation/genetics ; Liquid Biopsy
Czasopismo naukowe
Tytuł:
Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry.
Autorzy:
Cai JH; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Yang DY; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Zhang JJ; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Tan JH; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Huang ZS; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China. Electronic address: .
Chen SB; School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic chemistry [Bioorg Chem] 2024 Mar; Vol. 144, pp. 107173. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/chemistry
G-Quadruplexes*
Aniline Compounds*
Click Chemistry ; Proto-Oncogene Proteins c-myc ; Quinazolines/pharmacology ; Quinazolines/chemistry ; Triazoles/pharmacology ; Ligands
Czasopismo naukowe
Tytuł:
Reduced SV2A and GABA A receptor levels in the brains of type 2 diabetic rats revealed by [ F]flumazenil PET.
Autorzy:
Kong Y; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Cao L; PET Center, Huashan Hospital, Fudan University, Shanghai, China; Inst. Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Xie F; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Wang X; Dept. Neurology, Shanghai Sixth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zuo C; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Shi K; Dept. Nuclear Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.
Rominger A; Dept. Nuclear Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.
Huang Q; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Xiao J; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Jiang D; PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Guan Y; PET Center, Huashan Hospital, Fudan University, Shanghai, China. Electronic address: .
Ni R; Inst. Regenerative Medicine, University of Zurich, Zurich, Switzerland; Dept. Nuclear Medicine, Inselspital, Bern University Hospital, Bern, Switzerland; Inst. Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Mar; Vol. 172, pp. 116252. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/metabolism
Diabetes Mellitus, Experimental*/metabolism
Aniline Compounds*
Pyridines*
Fluorine Radioisotopes*
Pyrrolidines*
Ethylene Glycols*
Rats ; Animals ; Flumazenil/metabolism ; Receptors, GABA-A/metabolism ; Synaptic Vesicles/metabolism ; Proteomics ; Rats, Zucker ; Positron-Emission Tomography/methods ; Brain/diagnostic imaging ; Brain/metabolism ; gamma-Aminobutyric Acid/metabolism
Czasopismo naukowe
Tytuł:
Genomic evolutional analysis of surgical resected specimen to assess osimertinib as a first-line therapy in two patients with lung cancer harboring EGFR mutation: Case series.
Autorzy:
Koba H; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Yoneda T; Respiratory Medicine, Komatsu Municipal Hospital, Komatsu, Japan.
Morita H; Respiratory and Allergic Medicine, Morita Hospital, Komatsu, Japan.
Kimura H; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Murase Y; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Terada N; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Tambo Y; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Horie M; Department of Molecular and Cellular Pathology, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Kasahara K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Matsumoto I; Department of Thoracic Surgery, Kanazawa University, Kanazawa, Japan.
Yano S; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 661-666. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; ErbB Receptors/metabolism ; Genomics ; Disease Progression ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Efficacy and safety of 40 mg osimertinib administered every other day for non-small cell lung cancer harboring an epidermal growth factor receptor mutation: A single-center retrospective cohort study.
Autorzy:
Otsuki A; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Inoshima N; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Tochigi K; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Ito H; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Nakashima K; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 570-574. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/chemically induced
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/chemically induced
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Retrospective Studies ; Mutation ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/adverse effects ; Weight Loss
Czasopismo naukowe
Tytuł:
EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study.
Autorzy:
Araki T; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Kanda S; Department of Hematology and Medical Oncology, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan. Electronic address: .
Obara M; Department of Pharmacy, Shinshu University Hospital, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Agatsuma T; Department of Respiratory Medicine, Shinshu Ueda Medical Center, 1-27-21, Midorigaoka, Ueda, Nagano, 386-8610, Japan.
Kakizaki Y; Lung Cancer and Respiratory Disease Center, Yamanashi Prefectural Central Hospital, 1-1-1, Fujimi, Kofu, Yamanashi, 400-8506, Japan.
Hama M; Department of Respiratory Medicine, Japanese Red Cross Society Suwa Hospital, 5-11-50, Kogandori Suwa, Nagano, 390-0027, Japan.
Yamamoto H; Department of Respiratory Medicine, Iida Municipal Hospital, 438, Yawatamachi, Iida, 395-0814, Japan.
Takada M; Department of Respiratory Medicine, Jiseikai Aizawa Hospital, 2-5-1, Honjo, Matsumoto, Nagano, 390-8510, Japan.
Yamamoto M; Department of Respiratory Medicine, Japanese Red Cross Society Nagano Hospital, 5-22-1, Wakasato, Nagano, Nagano, 380-8582, Japan.
Matsuo A; Department of Respiratory Medicine, Minaminagano Medical Center, 666-1, Shinonoiai, Shinonoi General Hospital, 388-8004, Nagano, Japan.
Kondo D; Department of Respiratory Medicine, Hokushin General Hospital, 1-5-63, Nishi, Nakano, Nagano, 383-8505, Japan.
Komatsu M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Sonehara K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Tateishi K; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Hanaoka M; First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Koizumi T; Department of Hematology and Medical Oncology, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, Nagano, 390-8621, Japan.
Pokaż więcej
Źródło:
Respiratory investigation [Respir Investig] 2024 Mar; Vol. 62 (2), pp. 262-268. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Multicenter Study; Observational Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Retrospective Studies ; ErbB Receptors/genetics ; Disease Progression ; Mutation ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Tytuł:
H 2 O ⋅ B(C 6 F 5 ) 3 -Catalyzed para-Alkylation of Anilines with Alkenes Applied to Late-Stage Functionalization of Non-Steroidal Anti-Inflammatory Drugs.
Autorzy:
Winfrey L; School of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Yun L; School of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Passeri G; School of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Suntharalingam K; School of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Pulis AP; School of Chemistry, University of Leicester, Leicester, LE1 7RH, United Kingdom.
Pokaż więcej
Źródło:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2024 Mar 01; Vol. 30 (13), pp. e202303130. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Alkenes*/chemistry
Aniline Compounds*/chemistry
Alkylation ; Anti-Inflammatory Agents, Non-Steroidal ; Catalysis
Czasopismo naukowe
Tytuł:
Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system.
Autorzy:
Ogawa T; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Ono K; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Ryumon S; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Kawai H; Department of Oral Pathology and Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Nakamura T; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Umemori K; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yoshida K; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Kanemoto H; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Obata K; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yoshioka N; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Okui T; Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Shimane, Japan.
Okamoto K; Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Nagatsuka H; Department of Oral Pathology and Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Ibaragi S; Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Pokaż więcej
Źródło:
Head & neck [Head Neck] 2024 Mar; Vol. 46 (3), pp. 636-650. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Extracellular Vesicles*/metabolism
Aniline Compounds*
Benzylidene Compounds*
Humans ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Copper Transport Proteins ; Drug Resistance, Neoplasm ; Cell Line, Tumor ; Copper/metabolism ; Copper/pharmacology
Czasopismo naukowe
Tytuł:
SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.
Autorzy:
Theard PL; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Linke AJ; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Sealover NE; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Daley BR; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Yang J; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Cox K; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Kortum RL; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Molecular oncology [Mol Oncol] 2024 Mar; Vol. 18 (3), pp. 641-661. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/metabolism ; Receptor Protein-Tyrosine Kinases/genetics ; Mutation/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł:
Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner.
Autorzy:
Rubinski A; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.
Dewenter A; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.
Zheng L; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.
Franzmeier N; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.
Stephenson H; Department of Medicine, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, WI, USA.
Deming Y; Department of Medicine, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, WI, USA.
Duering M; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.; Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
Gesierich B; Medical Image Analysis Center (MIAC) and Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
Denecke J; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.
Pham AV; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany.; Department of Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.
Bendlin B; Department of Medicine, School of Medicine and Public Health, University of Wisconsin- Madison, Madison, WI, USA.
Ewers M; Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilian-University Munich, Munich, Germany. .; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. .
Pokaż więcej
Corporate Authors:
Alzheimer’s Disease Neuroimaging Initiative
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Mar; Vol. 51 (4), pp. 1035-1049. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Cognitive Dysfunction*/metabolism
Demyelinating Diseases*/metabolism
Aniline Compounds*
Ethylene Glycols*
Humans ; Apolipoprotein E4/genetics ; Amyloid beta-Peptides/metabolism ; Apolipoproteins E ; Brain/metabolism ; tau Proteins/metabolism ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł:
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Autorzy:
Chen N; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Pan J; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Zhou Y; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Mao L; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Lou Y; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Qian J; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Xu G; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Wei J; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Zhou; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Shou L; Department of Hematology, Huzhou Central Hospital, Huzhou, Zhejiang, PR China.
Huang L; Jinhua People's Hospital, Jinhua, Zhejiang, PR China.
Yan M; Department of Hematology, the First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, PR China.
Zeng H; Department of Hematology, the First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, PR China.
Fan C; Shulan (Hangzhou) Hospital, Zhejiang Shuren University Shulan International Medical College, Hangzhou, Zhejiang, PR China.
Wu G; Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang People's Hospital, Dongyang, Zhejiang, PR China.
Feng W; Department of Hematology, Shaoxing People's Hospital, Shaoxing, Zhejiang, PR China.
Tong H; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.
Jin J; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.; Zhejiang University Cancer Center, Hangzhou, Zhejiang, PR China.
Wang H; Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China.; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, Zhejiang, China.; Zhejiang University Cancer Center, Hangzhou, Zhejiang, PR China.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 861-870. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
fms-Like Tyrosine Kinase 3*
Leukemia, Myeloid, Acute*
Aniline Compounds*
Pyrazines*
Sulfonamides*
Bridged Bicyclo Compounds, Heterocyclic*
Adult ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma.
Autorzy:
Liang J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Bi G; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Sui Q; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhao G; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhang H; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Bian Y; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Chen Z; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Huang Y; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Xi J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Shi Y; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Wang Q; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: .
Zhan C; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: .
Pokaż więcej
Źródło:
Cell reports [Cell Rep] 2024 Feb 27; Vol. 43 (2), pp. 113771. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Animals ; Humans ; Transcription Factors/genetics ; Neoplasm, Residual ; ErbB Receptors/genetics ; DNA-Binding Proteins
Czasopismo naukowe
Tytuł:
Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting system.
Autorzy:
Zhao D; Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), 621000, Mianyang, Sichuan, People's Republic of China. .
Long X; Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), 621000, Mianyang, Sichuan, People's Republic of China.
Wang J; Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), 621000, Mianyang, Sichuan, People's Republic of China. .
Pokaż więcej
Źródło:
BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2024 Feb 23; Vol. 25 (1), pp. 20. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Tyrosine Kinase Inhibitors*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/chemically induced
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Aniline Compounds*
Nitriles*
Quinolines*
Humans ; Imatinib Mesylate ; Dasatinib/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Pharmacovigilance ; Fusion Proteins, bcr-abl/therapeutic use ; Pyrimidines/therapeutic use
Czasopismo naukowe
Tytuł:
Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFR /ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers.
Autorzy:
Wang A; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Shuai W; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Wu C; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Pei J; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Yang P; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Wang X; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Li S; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Liu J; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Wang Y; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Wang G; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Ouyang L; Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
Pokaż więcej
Źródło:
Journal of medicinal chemistry [J Med Chem] 2024 Feb 22; Vol. 67 (4), pp. 2777-2801. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Animals ; Mice ; ErbB Receptors/metabolism ; Drug Resistance, Neoplasm ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/chemistry ; Cell Line, Tumor
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies